Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion type Assertion NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_head.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion description "[Patients with COX-2 methylated tumors had significantly longer time to recurrence and improved overall survival in a multivariate analysis in the validation patient group (hazard ratio[HR], 0.49; 95% CI, 0.24% to 0.99%; HR, 0.62; 95% CI, 0.38% to 0.99%, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_provenance.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion evidence source_evidence_literature NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_provenance.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion SIO_000772 17971584 NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_provenance.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion wasDerivedFrom befree-20150227 NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_provenance.
- NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_assertion wasGeneratedBy ECO_0000203 NP658457.RAPC0D1LEaGT5ID8dtP5YGSj1RuEOG-Qw5zpWhakY_KAk130_provenance.